In this article, we discover several examples of “digital therapeutics”. Even if this new kind of drugs is not so new, first were used 10 years ago, we have seen a lot of new solutions in the previous 2 or 3 years. More and more clinical trials are ongoing and most of the biggest pharmaceuticals industries work on it. Authors describe the history of this domain and explain in particular links with more classical drugs and treatments.
Improvements in VR technology and falling costs are raising hopes that its use might become more widespread in medicine. “VR has been used for 25 years, but only for very few conditions, in specialist centres,” says Freeman. The technology has seen most use in delivering exposure therapy for post-traumatic stress disorder, and this is still the leading application. But it also has potential uses in depression, anxiety, phobias, obsessive–compulsive disorder, eating disorders, addiction and psychosis.
Source: The emerging world of digital therapeutics
